Back

First Eurasian cases of SARS-CoV-2 seropositivity in a free-ranging urban population of wild fallow deer

Purves, K.; Brown, H.; Haverty, R.; Ryan, A.; Griffin, L.; McCormack, J.; O'Reilly, S. R.; Mallon, P. W.; Gautier, V.; Cassidy, J. P.; Fabre, A.; Carr, M. J.; Gonzalez, G.; Ciuti, S.; Fletcher, N.

2023-07-07 microbiology
10.1101/2023.07.07.547941 bioRxiv
Show abstract

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infects wildlife. Recent studies highlighted that variants of concern (VOC) may expand into novel animal reservoirs with the potential for reverse zoonosis. North American white-tailed deer are the only deer species in which SARS-CoV-2 has been documented, raising the question whether further reservoir species exist as new VOC emerge. Here, we report the first cases of deer SARS-CoV-2 seropositivity in Eurasia, in a city population of fallow deer in Dublin, Ireland. Deer were seronegative in 2020 (circulating variant in humans: Alpha), one animal was seropositive in 2021 (Delta variant), and 57% of animals tested in 2022 were seropositive (Omicron variant). Ex vivo, a clinical isolate of Omicron BA.1 infected fallow deer precision cut lung slice type-2 pneumocytes, also a major target of infection in human lungs. Our findings suggest a change in host tropism as new variants emerged in the human reservoir, highlighting the importance of continued wildlife disease monitoring and limiting human-wildlife contacts. Teaser: This study is the first report of SARS-CoV-2 seropositivity in fallow deer, highlighting expansion of viral variants into new host reservoirs.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
Emerging Infectious Diseases
103 papers in training set
Top 0.1%
27.7%
2
One Health
29 papers in training set
Top 0.1%
17.5%
3
Emerging Microbes & Infections
74 papers in training set
Top 0.1%
10.4%
50% of probability mass above
4
Transboundary and Emerging Diseases
34 papers in training set
Top 0.1%
6.3%
5
Nature Communications
4913 papers in training set
Top 37%
4.0%
6
Viruses
318 papers in training set
Top 2%
3.6%
7
Scientific Reports
3102 papers in training set
Top 41%
3.1%
8
Journal of Virology
456 papers in training set
Top 2%
1.7%
9
PLOS Pathogens
721 papers in training set
Top 6%
1.7%
10
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 35%
1.5%
11
mSphere
281 papers in training set
Top 4%
1.3%
12
PLOS ONE
4510 papers in training set
Top 58%
1.3%
13
Journal of General Virology
46 papers in training set
Top 0.5%
1.2%
14
Clinical Infectious Diseases
231 papers in training set
Top 4%
1.0%
15
The Journal of Infectious Diseases
182 papers in training set
Top 5%
0.8%
16
Infectious Diseases
14 papers in training set
Top 0.2%
0.8%
17
iScience
1063 papers in training set
Top 32%
0.7%
18
Royal Society Open Science
193 papers in training set
Top 5%
0.7%
19
PeerJ
261 papers in training set
Top 17%
0.6%
20
Journal of Infection
71 papers in training set
Top 3%
0.6%
21
International Journal of Molecular Sciences
453 papers in training set
Top 18%
0.6%
22
Frontiers in Immunology
586 papers in training set
Top 9%
0.6%
23
Journal of Travel Medicine
18 papers in training set
Top 0.4%
0.6%
24
The Lancet Infectious Diseases
71 papers in training set
Top 3%
0.6%